The HPV Vaccine's Power to Prevent Cancer
U.S. News & World Report
By Kristine Crane
Anna Giuliano, a cancer researcher at Moffitt Cancer Center in Tampa, Florida, poses a question: “Let’s say we have a vaccine to prevent breast or prostate cancer. Do you think we would have any pushback?”
And yet, Giuliano continues, we have a vaccine that prevents an infection that is the leading cause of multiple cancers, and less than 50 percent of the target population gets it.
The human papillomavirus vaccine, commonly known by its commercial names, Gardasil and Cervarix, is best known for protecting against cervical cancer in women. Lesser known is that it also protects against anal, penile and oropharyngeal cancers, the latter of which is one of the fastest growing cancers in the U.S. And the incidence in men is twice that of women.
Click here to read the full story.